Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

FDA is still struggling to inspect clinical research sites, watchdog finds

The U.S. Food and Drug Administration’s oversight of clinical research in hospitals and clinics has fallen considerably in recent years, due to disruptions caused by

March 26, 2024

Myrobalan secures funding for CNS drug development

Share this article Myrobalan will use the funds to develop drugs for treating ailments of the central nervous system (CNS). Credit: Billion Photos/Shutterstock.com. Myrobalan Therapeutics

January 11, 2024

AISAP’s AI-Powered Cardiac Ultrasound Receives FDA Clearance

What You Should Know: – AISAP, a medical technology company specializing in AI-powered point-of-care assisted diagnosis (POCAD) solutions, announced today that it has received FDA

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.